English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
REMINDER: Join us on Thursday Jan 23rd, 13.00 CET for CML Highlights of ASH 2024
January 2025 - This is a friendly reminder to join us for the CML Highlights of ASH 2024 webinar, the first iCMLf Conversation of 2025, taking place on:
📅Thursday, January 23rd, 2025
🕐 13:00 Central European Time (CET)
📍 Live webinar on Zoom (45 mins)
Click here for more information and times in other time zones.
Zoom Access: Click here to join
Meeting ID: 828 8939 5232
Hepatitis B and CML - Participate in the survey of practice
January 2025 - The risk of Hepatitis B Virus (HBV) reactivation in CML patients under TKI therapy has been reported, but there are no clear guidelines and recommendations regarding screening and monitoring of HBV in CML patients receiving TKIs and experience on Hepatitis B reactivation under CML treatment is limited.
On the initiative of Professor Dragana Milojkovic (Imperial College London, UK), the iCMLf has formed a HBV and CML Working Group to answer open research questions. This group will collect and collate global experiences of physicians treating people with CML and HBV, with the aim of developing recommendations on monitoring and treatment for HBV in patients with CML.
The iCMLf Hepatitis B virus (HBV) Screening and Management Survey is now open and we would be delighted to learn from you.
INVITATION: CML Highlights of ASH 2024 on Jan 23rd at 1 pm CET
December 2024 - We are delighted to invite you to our ‘CML Highlights of ASH 2024’ webinar, the first iCMLf Conversation of 2025, where we will present key insights and updates from the 66th American Society of Hematology (ASH) Meeting 2024.
If you missed the ASH 2024 Meeting or want an expert overview, this webinar offers a concise and comprehensive summary of the key CML clinical and biological highlights from the conference.
Join us on Thursday, January 23rd, 2025 at 13.00 CET to hear from two world-renowned experts:
- Professor Timothy Hughes:
Sharing clinical advancements in CML presented at ASH 2024 - Professor Susan Branford:
Highlighting biological breakthroughs in CML presented at ASH 2024
iCMLf Forum 2024: Shaping the Future of Treatment-Free Remission in CML
The iCMLf Forum, held on December 7th during the American Society of Hematology meeting in San Diego, brought together leading clinicians, researchers, and patient advocates to explore groundbreaking advancements in the pursuit of treatment-free remission (TFR) for patients with CML. This year’s Forum focused on Advancing TFR globally, overcoming the barriers in LMICs and looking to the future of potential biomarkers along with the biological barriers to cure CML.
Together for a Cure: Reflecting on 2024 and Looking Ahead
As 2024 comes to a close, we reflect on an extraordinary year for the iCMLf community - one defined by progress, collaboration, and a shared determination to improve outcomes for people living with CML.
Meet the iCMLf at ASH 2024 and at the iCMLf Fourm on Dec 6th
December 2024 - The 66th ASH Annual Meeting kicks off this Saturday with nearly 8,000 abstracts and key CML highlights await.
For those of you attending ASH in person, there will be many opportunities for collaboration and we look forward to meeting you there! If you would like to arrange a meeting with the iCMLf, please reach out at info@cml-foundation.org.
There’s still time to register for the iCMLf Forum at ASH on December 6th that will be chaired by iCMLf Director, Dr Katia Pagnano. This is your chance to connect with global experts and discuss ideas and developments to advance treatment-free remission in CML globally.
